Healthcare Profesionals
Tuberculosis
T-SPOT®.TB Overview
Economic Impact
Regulatory Information
Frequently Asked Questions
Healthcare Profesionals
Patients
About Tuberculosis
Diagnosing Tuberculosis
Why Request T-SPOT®.TB?
TB Vaccination and Treatment
Frequently Asked Questions
Patients
Media Members
Media Requests
Consumers
Latest News
  • Oxford Immunotec Announces that the Centers for Medicare and Medicaid Services (CMS) Increases Reimbursement for the T-SPOT®.TB Test CPT® Code 86481
  • Federal Supply Schedule (FSS) Contract Awarded to Oxford Diagnostic Laboratories for T-SPOT®.TB Testing
  • Study Results Show Switching from the Tuberculin Skin Test (TST) to an Interferon Gamma Release Assay (IGRA) can Improve Healthcare Worker Test Adherence at a Lower Cost
Bookmark and Share
Follow us
Get Email Updates
  • About
  • Product Overview
  • News and Meetings
  • Resources
  • Careers
  • Contact
  • Site Map
  • Terms of Use



T-SPOT®.TB and the Oxford Immunotec logo are trademarks of Oxford Immunotec | © 2010 Oxford Immunotec